IPAR.NASDAQInterparfums INC

Form 4: Interparfums Officer Herve Bouillonnec Boosts Equity Holdings

Sentiment:

Insider Transaction Report


Interparfums Global Chief Commercial Officer Herve Bouillonnec reported beneficial ownership of 1,500 common shares and acquired 4,000 new stock options with an exercise price of $84.64.

Summary

  • Herve Bouillonnec, a Director and Global Chief Commercial Officer of INTERPARFUMS INC (IPAR), reported his beneficial ownership of company securities.
  • He directly owns 1,500 shares of Common Stock.
  • Bouillonnec holds multiple tranches of stock options to buy Common Stock:
  • 5,000 options with an exercise price of $97.84, granted on 12/31/2023, vesting annually from 12/31/2023 to 12/31/2027, and expiring on 12/30/2028.
  • 4,000 options with an exercise price of $147.71, granted on 12/29/2024, vesting annually from 12/29/2024 to 12/29/2028, and expiring on 12/28/2029.
  • 4,000 options with an exercise price of $130.60, granted on 12/31/2025, vesting annually from 12/31/2025 to 12/31/2029, and expiring on 12/30/2030.
  • 4,000 options with an exercise price of $84.64, acquired on 12/31/2025, vesting annually from 12/31/2026 to 12/31/2030, and expiring on 12/30/2031.
  • In total, Bouillonnec beneficially owns 1,500 shares of common stock and 17,000 stock options.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a key executive and director is increasing their equity exposure through new option grants, indicating confidence in the company's future. However, it is a routine compensation disclosure, not a direct indicator of operational performance.

Positives

  • The acquisition of 4,000 new stock options by a key executive and director aligns management's interests with shareholder value, as the options gain value if the stock price increases.
  • The continued accumulation of equity and options by a Global Chief Commercial Officer indicates confidence in the company's future performance and growth prospects.

Negatives

  • The issuance of new stock options could lead to potential future dilution for existing shareholders if these options are exercised.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's financial performance or strategic direction, beyond the vesting and expiration schedules of the granted stock options.

Industry Context

This insider transaction report reflects routine executive compensation practices within the consumer discretionary and fragrance industry, where stock options are commonly used to incentivize management and align their long-term interests with company performance.

Stakeholder Impact

  • Shareholders: Potential for increased alignment of management's interests with shareholder value, but also potential for future share dilution upon option exercise.
  • Employees: The compensation structure, including stock options, can serve as a model for other key employees, potentially impacting morale and retention.

Next Steps

  • The various tranches of stock options will continue to vest annually on their respective schedules, with the latest vesting period extending to 12/31/2030 for the $84.64 options.
  • The reporting person may choose to exercise vested options prior to their respective expiration dates.

Key Dates

DateDescription
12/31/2023Transaction date for 5,000 stock options with an exercise price of $97.84; first exercisable date for this tranche.
12/29/2024Transaction date for 4,000 stock options with an exercise price of $147.71; first exercisable date for this tranche.
12/31/2025Date of earliest transaction reported in the filing header; transaction date for 4,000 stock options with an exercise price of $130.60 and acquisition date for 4,000 stock options with an exercise price of $84.64; first exercisable date for $130.60 options.
01/05/2026Signature date of the reporting person for the filing.
12/30/2028Expiration date for stock options with an exercise price of $97.84.
12/28/2029Expiration date for stock options with an exercise price of $147.71.
12/30/2030Expiration date for stock options with an exercise price of $130.60.
12/30/2031Expiration date for stock options with an exercise price of $84.64.

Keywords

Interparfums, IPAR, Herve Bouillonnec, Stock Options, Insider Ownership, Executive Compensation, Beneficial Ownership, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.